Insulin resistance and Parkinson's disease: a new target for disease modification?

D Athauda, T Foltynie - Progress in neurobiology, 2016 - Elsevier
There is growing evidence that patients with Type 2 diabetes have an increased risk of
developing Parkinson's disease and share similar dysregulated pathways suggesting …

Leptin signalling pathways in hypothalamic neurons

O Kwon, KW Kim, MS Kim - Cellular and Molecular Life Sciences, 2016 - Springer
Leptin is the most critical hormone in the homeostatic regulation of energy balance among
those so far discovered. Leptin primarily acts on the neurons of the mediobasal part of …

The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications

M Teimouri, H Hosseini, Z ArabSadeghabadi… - Journal of physiology …, 2022 - Springer
Insulin resistance, the most important characteristic of the type 2 diabetes mellitus (T2DM), is
mostly caused by impairment in the insulin receptor (IR) signal transduction pathway …

Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy

J Pan, L Zhou, C Zhang, Q Xu, Y Sun - Signal transduction and targeted …, 2022 - nature.com
Inflammation is the common pathological basis of autoimmune diseases, metabolic
diseases, malignant tumors, and other major chronic diseases. Inflammation plays an …

Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders

S Singh, AS Grewal, R Grover, N Sharma, B Chopra… - Bioorganic …, 2022 - Elsevier
The aim of this review was to discuss an overview of type 2 diabetes; biology of PTP1B; role
of PTP1B in metabolic disorders; and recent updates in the development of PTP1B inhibitors …

[HTML][HTML] Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders

J Olloquequi, A Cano, E Sanchez-López… - Biomedicine & …, 2022 - Elsevier
Protein tyrosine phosphatase 1B (PTP1B) is a typical member of the PTP family, considered
a direct negative regulator of several receptor and receptor-associated tyrosine kinases …

Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine

M Perni, P Flagmeier, R Limbocker… - ACS chemical …, 2018 - ACS Publications
The aggregation of α-synuclein, an intrinsically disordered protein that is highly abundant in
neurons, is closely associated with the onset and progression of Parkinson's disease. We …

[HTML][HTML] Interleukin 13 receptor alpha 2 (IL13Rα2): expression, signaling pathways and therapeutic applications in cancer

M Jaén, Á Martín-Regalado, RA Bartolomé… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Abstract Interleukin 13 receptor alpha 2 (IL13Rα2) is increasingly recognized as a relevant
player in cancer invasion and metastasis. Despite being initially considered a decoy …

Brain signaling systems in the type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases

AO Shpakov, KV Derkach, LM Berstein - Future science OA, 2015 - Taylor & Francis
The changes in the brain signaling systems play an important role in etiology and
pathogenesis of Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MS), being a …

The role of protein tyrosine phosphatase (PTP)-1B in cardiovascular disease and its interplay with insulin resistance

SS Abdelsalam, HM Korashy, A Zeidan, A Agouni - Biomolecules, 2019 - mdpi.com
Endothelial dysfunction is a key feature of cardiovascular disorders associated with obesity
and diabetes. Several studies identified protein tyrosine phosphatase (PTP)-1B, a member …